 
        
        
         
                                 
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
 
                        
                    
| 靶点 | 
 | 
| Concentration | Treated Time | Description | References | |
| pigtail macaque PBMCs | pigtail macaque PBMCs | Evaluate the inhibitory effect of Lenacapavir on stHIV-A19 in pigtail macaque PBMCs | EBioMedicine. 2023 Sep;95:104764. | |
| human PBMCs | human PBMCs | Evaluate the inhibitory effect of Lenacapavir on stHIV-A19 in human PBMCs | EBioMedicine. 2023 Sep;95:104764. | |
| SupT1-CCR5 cells | SupT1-CCR5 cells | Evaluate the inhibitory effect of Lenacapavir on stHIV-A19, showing comparable efficacy to HIV-1 NL4-3 | EBioMedicine. 2023 Sep;95:104764. | |
| rhesus PBMCs | rhesus PBMCs | To evaluate the in vitro antiviral activity of Lenacapavir against SHIV, showing potent inhibition. | J Clin Invest. 2023 Aug 15;133(16):e167818. | |
| TZM-bl cells | TZM-bl cells | Determine antiviral potency of LEN at the lowest p24 levels, EC50 was 60 pM | PLoS Pathog. 2025 Jan 27;21(1):e1012862. | |
| Jurkat/Vpr-HiBiT T cells | Jurkat/Vpr-HiBiT T cells | Screened compounds inhibiting HIV-1 release, identified 10 candidate compounds | J Biol Chem. 2024 Sep;300(9):107701. | 
| Administration | Dosage | Frequency | Description | References | ||
| Pigtail macaques | StHIV-A19 infection model | Subcutaneous injection | 25 mg/kg | Single injection, virus challenge after 30 days | Evaluate the preventive effect of Lenacapavir against stHIV-A19 in pigtail macaques, showing all treated animals were protected from infection | EBioMedicine. 2023 Sep;95:104764. | 
| Rhesus macaques | SHIV rectal challenge model | Subcutaneous injection | 5-75 mg/kg | Single dose, monitored up to 25 weeks | To evaluate the pharmacokinetic profile and prophylactic efficacy of Lenacapavir in rhesus macaques. Results showed long plasma half-life and complete protection against SHIV infection when plasma drug concentrations exceeded 70 nM. | J Clin Invest. 2023 Aug 15;133(16):e167818. | 
| 计算器 | ||||
| 存储液制备 |  | 1mg | 5mg | 10mg | 
| 1 mM 5 mM 10 mM | 1.03mL 0.21mL 0.10mL | 5.16mL 1.03mL 0.52mL | 10.33mL 2.07mL 1.03mL | |
| CAS号 | 2189684-44-2 | 
| 分子式 | C39H32ClF10N7O5S2 | 
| 分子量 | 968.28 | 
| SMILES Code | FC(F)(F)CN(N=C1NS(C)(=O)=O)C2=C1C(Cl)=CC=C2C3=CC=C(C#CC(C)(S(C)(=O)=O)C)N=C3[C@H](CC4=CC(F)=CC(F)=C4)NC(CN5N=C(C(F)(F)F)C6=C5C(F)(F)[C@H]7[C@@H]6C7)=O | 
| MDL No. | N/A | 
| 别名 | GS-6207 | 
| 运输 | 蓝冰 | 
| 存储条件 | In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C | 
| 溶解方案 | DMSO: 190 mg/mL(196.22 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 
 
 | 
 沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1